Search filters

FoRx Therapeutics AG raises EUR 10M Seed-Financing round

FoRx Therapeutics AG, a Basel-based biotechnology company developing a new generation of cancer drugs focusing on novel DNA Replication Stress (DRS) pathways activated in cancer, completes a EUR 10M seed-financing round led by M...

MCAM Symalit acquires Recycling Activities from Minger Kunststofftechnik

MCAM Symalit AG, Lenzburg, a group company of the Mitsubishi Chemical Advanced Materials group, a leading global manufacturer of high-performance materials, takes over all Recycling related activities and assets, current...

Westermo acquires Neratec

Westermo, a subsidiary of Beijer Electronics Group AB (STO:BELE), has acquired 100% of the shares of Neratec Solutions AG, a technology company specialized in WLAN products for the train and trackside sector, headquartered in...

Kuros Biosciences enters convertible bond agreement

Kuros Biosciences AG (Kuros) entered into a convertible bond financing agreement with Nice & Green SA for up to a maximum of CHF 5 million. The facility is provided by Nice & Green SA (N&G), a private Swiss company which...

Control4 acquires 100% in NEEO AG

Control4 Corporation (NASDAQ:CTRL), a leading global provider of smart home solutions, acquired 100% in NEEO AG. NEEO AG is the Swiss based creator of an acclaimed smart home remote.   VISCHER advised Control4 on all legal aspects...

Planzer acquires Leimgruber

Planzer, an international logistics and transport group with main seat in Dietikon ZH, has acquired all shares of Paul Leimgruber AG, also a family-led logistics and transport business with main seat in Basel and approx. 300...

VISCHER advises Syngenta on divestment of sugar beet seeds business

VISCHER advises Syngenta on all aspects of Swiss law in its divestment of the global sugar beet seeds business. Syngenta is one of the largest agrichemical groups worldwide, with a workforce of more than 28,000 across 90...

Persistent Systems acquires PARX

Persistent Systems (BSE and NSE: PERSISTENT) acquires PARX, a Salesforce Certified Platinum Partner in the DACH market of Germany, Austria and Switzerland that focuses on its customers’ business models, strategic and operational...

Celgene acquires EngMab

Celgene (NASDAQ: CELG) has bought Swiss biotech EngMab for USD 600 million. EngMab's focus is on T-cell bispecific antibodies (TCBs). TCBs bind simultaneously to a target on a tumor cell and to the T-cell receptor complex, leading...

Barnes Group acquires Priamus System Technologies

Barnes Group Inc., an international industrial and aerospace manufacturer and service Provider listed on the New York stock exchange, has acquired Swiss privately held Priamus System Technologies, a technology leader in the...

You are currently offline. Some pages or content may fail to load.